- Home
- DOCN vs CORT Comparison
DOCN vs CORT Comparison
Compare DOCN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCN | CORT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DOCN | CORT |
|---|---|---|
| Price | $63.10 | $44.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $48.85 | ★ $114.20 |
| AVG Volume (30 Days) | 2.1M | ★ 3.4M |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 201.90 | N/A |
| EPS | ★ 2.64 | 0.87 |
| Revenue | ★ $863,962,000.00 | $741,172,000.00 |
| Revenue This Year | $17.17 | $21.70 |
| Revenue Next Year | $18.96 | $30.13 |
| P/E Ratio | ★ $22.34 | $52.25 |
| Revenue Growth | 14.20 | ★ 17.92 |
| 52 Week Low | $25.45 | $32.99 |
| 52 Week High | $61.67 | $117.33 |
Technical Indicators
Market Signals| Indicator | DOCN | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 73.90 | 41.96 |
| Support Level | $49.08 | $34.06 |
| Resistance Level | $57.00 | $45.67 |
| Average True Range (ATR) | 2.81 | 1.95 |
| MACD | 0.69 | 2.19 |
| Stochastic Oscillator | 94.18 | 95.91 |
Price Performance
Historical ComparisonAbout DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.